Training Program Metrics 2015-2020
|
| T32 Trainees (n=26) |
# (%) |
| Research Type |
|
| Basic Research |
12 (46%) |
| Clinical Research |
11 (42%) |
| Basic/translational or Clinical/ Translational |
3 (11%) |
| Track Distribution |
|
| Track I: Transfusion Medicine & Hemoglobinopathies |
5 (19%) |
| Track II: Hemostasis & Thrombosis |
4 (15%) |
| Track III: Hematopoeisis & Cellular Therapy |
16 (61%) |
| Track IV: Mol. Biology/signaling |
1 (4%) |
| Graduate Trainee Outcomes (n=19) |
|
| Academic/Clinic-based/Industry |
16 (84%) |
| Private Practice |
3 (16%) |
| Graduates in Research-related careers (n=16) |
|
| Academic Medical Center |
10 (63%) |
| Industry |
3 (19%) |
| Clinical Group |
2 (12%) |
| Government |
1 (7%) |
